{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T06:33:41Z","timestamp":1767335621750,"version":"3.48.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"crossref","award":["2022-N-01-5"],"award-info":[{"award-number":["2022-N-01-5"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe aortic stenosis (AS) imposes sustained pressure overload on the left ventricle, leading to hypertrophy and myocardial fibrosis, which are key features of adverse cardiac remodeling. Timely transcatheter aortic valve replacement (TAVR) may reverse these processes. Transfemoral access remains the primary access method for TAVR, but the limited technique restricts early intervention in patients with narrow femoral arteries. This study aimed to evaluate the safety and feasibility of a novel balloon dilation in sheath (BinS) technique designed to facilitate transfemoral TAVR in such patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter, prospective, and first-in-human early feasibility study included patients with severe AS and challenging femoral anatomy who underwent TAVR using the BinS technique between February 2023 and August 2024. The primary endpoint was the 30-day rate of major adverse events. The secondary endpoint was the rate of major adverse events at 6\u202fmonths. The clinical endpoints included major post-procedural complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifteen patients (mean age 73.5\u202f\u00b1\u202f7.3\u202fyears; 66.7% male) were treated successfully with the BinS technique via transfemoral access. There were no cases of all-cause mortality, stroke\/transient ischemic attack, or severe major vascular access site complications defined by Valve Academic Research Consortium (VARC)-3 at both 30\u202fdays and 6\u202fmonths. No myocardial infarction or paravalvular leakage was observed. 12 patients obtained VARC-3 technical success. Two patients experienced postprocedural arterial dissection, and two developed new-onset conduction abnormalities (left bundle branch block or permanent pacemaker implantation). At 30\u202fdays, left ventricular ejection fraction improved significantly from 50.8\u202f\u00b1\u202f17.0% pre-procedure to 59.9\u202f\u00b1\u202f14.6% post-procedure (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The BinS technique appears to be a safe and effective method for enlarging the narrow femoral lumens during TAVR. By broadening transfemoral TAVR eligibility, this approach may permit earlier hemodynamic unloading, thereby mitigating adverse cardiac remodeling and potentially improving long-term outcomes. Larger, longer-term studies are warranted to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1732507","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T06:29:10Z","timestamp":1767335350000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Balloon dilation in sheath technique in transcatheter aortic valve replacement via narrow femoral artery: first-in-human early feasibility study"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaoqian","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyi","family":"Qie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guihua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guipeng","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.21037\/cdt.2019.10.01","article-title":"Review of alternative access in Transcatheter aortic valve replacement","volume":"10","author":"Banks","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/npjbcancer.2016.6","article-title":"Decreased gastrointestinal toxicity associated with a novel Capecitabine schedule (7 days on and 7 days off): a systematic review","volume":"2","author":"Cadoo","year":"2016","journal-title":"NPJ Breast Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jacc.2024.11.051","article-title":"Transcatheter aortic valve replacement beyond severe aortic stenosis: Jacc state-of-the-art review","volume":"85","author":"Beerkens","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jacc.2021.01.012","article-title":"TAVR versus SAVR in aortic stenosis: long journey, new roadmap","volume":"77","author":"Prendergast","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jcin.2024.02.014","article-title":"Quality of life 5 years following transfemoral Tavr or Savr in intermediate risk patients","volume":"17","author":"Kleiman","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fcvm.2018.00088","article-title":"Access sites for Tavi: patient selection criteria, technical aspects, and outcomes","volume":"5","author":"Biasco","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jcin.2022.12.009","article-title":"Vascular access in patients with peripheral arterial disease undergoing tavr: the hostile registry","volume":"16","author":"Palmerini","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.114.012525","article-title":"Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (Partner)-I trial substudy","volume":"131","author":"Blackstone","year":"2015","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11886-016-0788-8","article-title":"Access options for Transcatheter aortic valve replacement in patients with unfavorable Aortoiliofemoral anatomy","volume":"18","author":"Patel","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jvs.2004.02.035","article-title":"Effect of ethnicity on access and device complications during endovascular aneurysm repair","volume":"40","author":"Masuda","year":"2004","journal-title":"J Vasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ijcard.2012.04.001","article-title":"Iliofemoral anatomy among Asians: implications for Transcatheter aortic valve implantation","volume":"167","author":"Chiam","year":"2013","journal-title":"Int J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e13491","DOI":"10.1111\/eci.13491","article-title":"The Iliofemoral tortuosity score predicts access and bleeding complications during Transfemoral Transcatheter aortic valve replacement: Datadata from the Vienna cardio thoracic aortic valve registry (victory)","volume":"51","author":"Mach","year":"2021","journal-title":"Eur J Clin Investig"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"907445","DOI":"10.3389\/fcvm.2022.907445","article-title":"Editorial: Transcatheter aortic valve implantation: all Transfemoral? Update on vascular Acccess and closure","volume":"9","author":"Cerillo","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jcin.2021.11.013","article-title":"Validation of the Varc-3 technical success definition in patients undergoing tavr","volume":"15","author":"Tomii","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.jcin.2021.08.024","article-title":"Outcomes of combined transcatheter aortic valve replacement and peripheral vascular intervention in the United States","volume":"14","author":"Bansal","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1397-e1406","DOI":"10.4244\/EIJ-D-21-00581","article-title":"Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study","volume":"17","author":"Nardi","year":"2022","journal-title":"EuroIntervention"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ccd.30576","article-title":"Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease","volume":"101","author":"Alvarez-Covarrubias","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1016\/j.jcin.2021.09.007","article-title":"Peripheral vascular intervention in patients with transcatheter aortic valve replacement: friend and foe","volume":"14","author":"Neumann","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jcin.2011.03.019","article-title":"Transfemoral aortic valve implantation new criteria to predict vascular complications","volume":"4","author":"Hayashida","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jacc.2011.08.069","article-title":"Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure","volume":"59","author":"Toggweiler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijcard.2017.07.083","article-title":"Transcatheter aortic valve replacement with new-generation devices: a systematic review and meta-analysis","volume":"245","author":"Barbanti","year":"2017","journal-title":"Int J Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/eurheartj\/ehx785","article-title":"Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review","volume":"39","author":"van Rosendael","year":"2018","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","article-title":"Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms","volume":"107","author":"Hein","year":"2003","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jcmg.2018.11.026","article-title":"Imaging and impact of myocardial fibrosis in aortic stenosis","volume":"12","author":"Bing","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","article-title":"Reverse myocardial remodeling following valve replacement in patients with aortic stenosis","volume":"71","author":"Treibel","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamacardio.2022.2222","article-title":"Association between early left ventricular ejection fraction improvement after Transcatheter aortic valve replacement and 5-year clinical outcomes","volume":"7","author":"Kolte","year":"2022","journal-title":"JAMA Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijcard.2021.03.053","article-title":"Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy","volume":"332","author":"Oh","year":"2021","journal-title":"Int J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12968-020-00629-9","article-title":"Cardiac structural changes after transcatheter aortic valve replacement: systematic review and meta-analysis of cardiovascular magnetic resonance studies","volume":"22","author":"Mehdipoor","year":"2020","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1732507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T06:29:11Z","timestamp":1767335351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1732507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":30,"alternative-id":["10.3389\/fmed.2025.1732507"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1732507","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"article-number":"1732507"}}